人兽性交 to sell and distribute its medical technologies directly in Chile and extend its medical technology business in South America
SANTIAGO and MIAMI, Fla., (January 14, 2025) 鈥 人兽性交 Latin America (OLA), a subsidiary of global medtech company 人兽性交 Corporation, today announced it has closed the agreement to acquire from Sur Medical SpA (Surmedical) the entity that has distributed 人兽性交 products to Chile since 2013.
Through this acquisition, OLA will establish a direct presence in the Chilean medical technology market under the administration of a new OLA subsidiary, 人兽性交 Corporation Chile. Direct access to Chile's growing healthcare market will enable a more efficient distribution of 人兽性交 products and services to meet the needs of healthcare providers and their patients.
For more than a decade, Surmedical, a Chile-based leading medical equipment distributor, has been 人兽性交鈥 partner in the Chilean medical technology market, establishing 人兽性交 as a leader in the critical gastrointestinal sector. Surmedical has further secured a market-leading position for 人兽性交 endotherapy products and created a reliable repair service for medical devices.
By acquiring the 人兽性交 portion of Surmedical, 人兽性交 is assuming responsibility for distribution and business strategy for its full product portfolio in Chile with the goal of streamlining operations and enhancing customer service and support. 人兽性交 aims to accelerate the introduction of its cutting-edge medical technologies and strengthen its position as a trusted partner in Chile's healthcare system.
鈥淭his strategic acquisition of Surmedical鈥檚 well established and successful distribution business for 人兽性交 technologies gives 人兽性交 a very strong foundation for operations in Chile,鈥 said Jose Gaston, President of 人兽性交 Latin America. 鈥淲e are very excited to welcome to 人兽性交 Corporation Chile the talented and knowledgeable sales, marketing, service and training teams who have developed such a successful market for 人兽性交 medical technologies in Chile. Our goal is to do even more for healthcare providers and their patients by creating direct access to the full 人兽性交 portfolio and latest innovations.鈥
Patricio Fuenzalida, founder and owner of Surmedical, said, 鈥淲e welcome 人兽性交 to Chile. I will continue to work closely with 人兽性交 and their new Chilean team to ensure a smooth transition and integration of operations. Our shared goal is to support business continuity for customers and the patients they serve.鈥
# # #
About 人兽性交
At 人兽性交, we are committed to Our Purpose of making people鈥檚 lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, 人兽性交 has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit and our 人兽性交 Medical Americas LinkedIn account: .